Arjuna Capital Makes New $247,000 Investment in Healthpeak Properties, Inc. $DOC

Arjuna Capital bought a new position in Healthpeak Properties, Inc. (NYSE:DOC) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 14,089 shares of the real estate investment trust’s stock, valued at approximately $247,000.

Several other institutional investors have also made changes to their positions in DOC. Deutsche Bank AG boosted its position in shares of Healthpeak Properties by 0.3% in the first quarter. Deutsche Bank AG now owns 8,482,898 shares of the real estate investment trust’s stock worth $171,524,000 after buying an additional 23,136 shares during the period. Adelante Capital Management LLC raised its position in Healthpeak Properties by 4,464.2% during the first quarter. Adelante Capital Management LLC now owns 1,189,069 shares of the real estate investment trust’s stock valued at $24,043,000 after buying an additional 1,163,017 shares during the period. Aviva PLC raised its position in Healthpeak Properties by 6.6% during the second quarter. Aviva PLC now owns 593,721 shares of the real estate investment trust’s stock valued at $10,396,000 after buying an additional 36,603 shares during the period. Alan B Lancz & Associates Inc. purchased a new stake in Healthpeak Properties in the 2nd quarter worth about $373,000. Finally, Chicago Partners Investment Group LLC acquired a new stake in Healthpeak Properties during the 2nd quarter worth about $205,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

DOC stock opened at $18.19 on Tuesday. The firm has a 50 day moving average of $18.26 and a two-hundred day moving average of $17.87. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $21.97. The company has a market capitalization of $12.64 billion, a price-to-earnings ratio of -363.63, a P/E/G ratio of 3.84 and a beta of 1.10. The company has a quick ratio of 1.28, a current ratio of 1.22 and a debt-to-equity ratio of 1.11.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The business had revenue of $705.87 million during the quarter, compared to analyst estimates of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. Healthpeak Properties’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.7%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio is -2,440.00%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on DOC shares. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a report on Monday, September 15th. Cantor Fitzgerald began coverage on shares of Healthpeak Properties in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective on the stock. Robert W. Baird cut their target price on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Weiss Ratings reissued a “sell (d+)” rating on shares of Healthpeak Properties in a research note on Monday, November 24th. Finally, Morgan Stanley lowered their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, August 22nd. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $20.91.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.